← Back to front page
Asia · Regional markets · Vietnam Investment Review

Bora Pharmaceuticals reports third quarter revenue and net income growth

Published by Vietnam Investment Review · Vietnam 9 h ago
Bora Pharmaceuticals reports third quarter revenue and net income growth
Bora Pharmaceuticals reports third quarter revenue and net income growth · Vietnam Investment Review

Detailed summary

Bora Pharmaceuticals announced third-quarter financial results on 13 November 2026 alongside operational updates confirming the completion of its manufacturing and biologics facilities in the United States.

HONG KONG SAR – Media OutReach Newswire – 13 November 2026 – Bora Pharmaceuticals ("Bora"; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 3Q2026 and provides 2027 outlook update. 3Q26 Business and Financial Highlights

Bobby Sheng, Chairman of Bora Group, stated, "In 2026, customers are choosing Bora because we combine onshore North American capacity with capabilities rarely found in a network of our size. Our focus now is execution: completing these commercial technology transfers in our US facilities on time, qualifying our new isolator fill-finish capacity, where 4 PPQ batches have been completed and 3 additional technology transfer programs are scheduled for 2027, and delivering on every quality commitment we have made.

Opening of the article, excerpted from Vietnam Investment Review. To read the rest, open the article on the publisher's site.

Read the full article on Vietnam Investment Review Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (vir.com.vn)

Also worth reading